Quotient Limited to Host Investor Day on July 16, 2018
June 18 2018 - 4:05PM
Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics
company, today announced that it will host an Investor Day on
Monday, July 16, 2018 from 9:00am – 1:00pm ET, in New York, NY. At
the event, Franz Walt, Chief Executive Officer of Quotient Limited,
along with other members of the management team, will provide a
briefing on how the Company’s MosaiQTM system is poised to meet the
significant unmet needs of the transfusion market.
This event is by invitation only and
registration is required. Investment professionals interested in
attending the event in-person can request an invitation by
contacting Mike Vallie at Westwicke Partners:
mike.vallie@westwicke.com.
The event will be webcast live on the Company’s
website at www.quotientbd.com. A replay of the event will be
available on the Company’s website following the event.
About Quotient Limited
Quotient is a commercial-stage diagnostics
company committed to reducing healthcare costs and improving
patient care through the provision of innovative tests within
established markets. With an initial focus on blood grouping and
serological disease screening, Quotient is developing its
proprietary MosaiQTM technology platform to offer a breadth of
tests that is unmatched by existing commercially available
transfusion diagnostic instrument platforms. The Company’s
operations are based in Edinburgh, Scotland; Eysins, Switzerland
and Newtown, Pennsylvania.
The Quotient logo and MosaiQ™ are registered
trademarks or trademarks of Quotient Limited and its subsidiaries
in various jurisdictions.
CONTACT: Chris Lindop, Chief
Financial Officer – chris.lindop@quotientbd.com; +41 22 545 52
26
Quotient (NASDAQ:QTNT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Quotient (NASDAQ:QTNT)
Historical Stock Chart
From Sep 2023 to Sep 2024